multiplex
pcr
becom
test
choic
detect
multipl
respiratori
virus
clinic
specimen
howev
direct
comparison
differ
pcr
assay
studi
compar
differ
multiplex
pcr
assay
recoveri
common
respiratori
virus
test
respiratori
specimen
use
four
differ
multiplex
pcr
assay
xtag
respiratori
viral
panel
fast
abbott
molecular
laboratori
fasttrack
respiratori
pathogen
assay
fasttrack
diagnost
easyplex
respiratori
pathogen
kit
ausdiagnost
inhous
multiplex
realtim
pcr
assay
perform
four
assay
similar
agreement
comparison
issu
throughput
technic
requir
cost
like
import
make
decis
assay
use
given
compar
perform
pcr
methodolog
detect
respiratori
pathogen
becom
commerci
avail
give
high
diagnost
yield
abil
detect
difficult
noncultur
pathogen
provid
clinic
relev
turnaround
time
bellaupujol
et
al
gadsbi
et
al
gunson
collin
carman
kuyper
et
al
murdoch
et
al
increas
sensit
pcr
classic
method
well
establish
murdoch
et
al
detect
newli
discov
respiratori
pathogen
human
bocaviru
schenk
et
al
rhinoviru
type
c
dominguez
et
al
contribut
improv
diagnost
yield
increas
accept
nucleic
acid
amplif
techniqu
naat
develop
high
throughput
assay
platform
chang
modern
diagnost
laboratori
oper
detect
respiratori
virus
emphasi
shift
cell
culturebas
method
viral
antigen
detect
use
pcr
standard
methodolog
kuyper
et
al
ganzenmuel
et
al
mahoni
et
al
techniqu
also
allow
quantit
pathogen
heim
et
al
jansen
et
al
ward
et
al
pcr
amplifi
product
use
genet
sequenc
monto
et
al
decid
pcr
assay
system
select
use
routin
diagnost
servic
complex
requir
systemat
evalu
laboratori
need
resourc
select
assay
depend
variabl
rang
pathogen
detect
expect
workload
workflow
financi
resourc
clinic
requir
staff
expertis
laboratori
abil
perform
assay
valid
varieti
commerci
inhous
pcr
assay
avail
use
multiplex
technolog
simplifi
workflow
significantli
reduc
process
time
gunson
et
al
multiplex
pcr
describ
public
refer
simultan
amplif
multipl
sequenc
singl
reaction
unfortun
rel
perform
assay
rare
compar
headtohead
studi
studi
directli
compar
perform
three
commerci
multiplex
pcr
assay
respiratori
viral
panel
fast
rvp
abbott
molecular
laboratori
chicago
usa
fasttrack
diagnost
ftd
respiratori
pathogen
fasttrack
junglinst
luxembourg
ep
respiratori
pathogen
kit
ausdiagnost
sydney
australia
establish
inhous
ih
multiplex
pcr
assay
respiratori
sampl
sent
canterburi
health
laboratori
christchurch
new
zealand
respiratori
pathogen
analysi
archiv
c
sampl
n
randomli
select
studi
without
knowledg
prior
test
result
includ
follow
specimen
type
throat
swab
note
turnaround
time
exclud
nucleic
acid
extract
time
n
nasal
swab
n
nasopharyngealpernas
swab
combin
throat
nasopharyngealpernas
swab
n
bronchoalveolar
lavag
n
sputum
n
tracheal
aspir
n
upper
respiratori
swab
site
state
n
nasopharyngealpernas
flock
swab
copan
diagnost
brescia
itali
throat
swab
medic
wire
wiltshir
unit
kingdom
collect
ml
viral
transport
media
vtm
copan
diagnost
brescia
itali
store
c
day
routin
test
complet
swab
nonspecifi
site
receiv
vtm
assum
nasopharyngealpernas
swab
bronchoalveolar
lavag
tracheal
aspir
sputum
specimen
receiv
steril
contain
process
homogenis
sampl
use
ratio
sputasol
oxoid
cambridg
unit
kingdom
addit
sputasol
ad
ensur
sampl
homogen
necessari
ratio
sputasol
studi
approv
upper
south
b
ethic
committe
christchurch
new
zealand
sampl
process
nucleic
acid
extract
use
platform
abbott
molecular
chicago
usa
total
nucleic
acid
protocol
recommend
manufactur
nucleic
acid
extract
l
sampl
elut
l
elut
buffer
perform
total
three
time
obtain
suffici
volum
nucleic
acid
four
pcr
assay
nucleic
acid
extract
sampl
pool
aliquot
four
deepwel
plate
abbott
molecular
chicago
usa
one
pcr
assay
prevent
freezethaw
damag
plate
store
c
test
templat
control
molecular
grade
water
extract
run
monitor
carryov
contamin
intern
control
ic
valid
neg
pcr
result
perform
recommend
manufactur
bacteriophag
xtag
rvp
fast
bromomosa
viru
bmv
fasttrack
diagnost
kit
easyplex
use
artifici
sequenc
inhous
assay
canterburi
health
laboratori
use
artifici
sequenc
insert
plasmid
unpublish
data
uniqu
found
human
clinic
sampl
inhous
multiplex
pcr
assay
base
assay
describ
gunson
et
al
notabl
differ
updat
influenza
pcr
ward
et
al
inclus
specif
probe
primer
detect
influenza
pdm
strain
whiley
et
al
human
metapneumoviru
maertzdorf
et
al
adenoviru
heim
et
al
differ
target
multiplex
pool
triplex
pcr
use
fam
vic
dye
l
pcr
reaction
mixtur
contain
primer
probe
concentr
reaction
avail
upon
request
agpathid
tm
onestep
rtpcr
buffer
rtpcr
enzym
appli
biosystem
life
technolog
melbourn
australia
l
nucleic
acid
extract
amplif
perform
abi
realtim
pcr
thermal
cycler
appli
biosystem
melbourn
australia
thermal
cycl
paramet
revers
transcriptas
rt
step
c
min
c
min
follow
pcr
cycl
c
c
commerci
multiplex
pcr
assay
perform
accord
manufactur
instruct
multiplex
pcr
specif
summaris
tabl
ftd
respiratori
pathogen
triplex
rtpcr
pool
per
sampl
requir
l
extract
nucleic
acid
pool
ftd
assay
pcr
perform
abi
appli
biosystem
melbourn
australia
use
thermal
cycl
profil
recommend
manufactur
ep
assay
requir
l
extract
sampl
respiratori
panel
l
extract
sampl
respiratori
pneumonia
panel
ep
pcr
perform
geneplex
system
includ
liquid
pipet
platform
rotorgen
ausdiagnost
sydney
australia
xtag
rvp
requir
l
extract
sampl
pcr
perform
geneamp
appli
biosystem
melbourn
australia
thermal
cycler
use
profil
recommend
manufactur
sensit
specif
determin
tabl
mcnemar
test
percentag
agreement
kappa
statist
calcul
comparison
assay
two
hundr
thirteen
respiratori
sampl
test
differ
assay
respiratori
viral
pathogen
target
common
assay
target
uniqu
singl
assay
analys
although
sampl
sequenti
pattern
viral
pathogen
detect
still
repres
local
epidemiolog
influenza
rsv
picornaviru
common
tabl
predomin
influenza
viru
strain
detect
pdm
isol
identifi
season
strain
circul
one
major
picornavirus
detect
rhinovirus
ftd
assay
assay
differenti
rhinoviru
within
picornaviru
famili
analysi
intern
control
result
assay
reveal
pcr
inhibit
ftd
ih
pcr
ep
assay
howev
inhibit
detect
sampl
pcr
xtag
rvp
assay
inhibit
sampl
sputum
pathogen
detect
indic
issu
sampl
matrix
pcr
statist
analysi
use
analyt
percentag
agreement
differ
assay
show
high
agreement
rate
rang
agreement
kappa
valu
rang
bocaviru
ftd
vs
easyplex
influenza
viru
ih
vs
ep
see
tabl
result
influenza
virus
detect
influenza
result
parainfluenza
virus
pool
parainfluenza
type
detect
result
strain
coronaviru
detect
high
degre
correl
found
ftd
xtag
rvp
ep
inhous
assay
agreement
assay
influenza
rsv
parainfluenza
virus
picornavirus
adenovirus
hmpv
coronavirus
human
bocaviru
rang
highest
analyt
agreement
detect
influenza
rsv
good
agreement
also
seen
detect
parainfluenza
virus
coronaviru
limit
number
sampl
contain
virus
test
therefor
evalu
would
use
confirm
observ
variat
seen
analyt
agreement
pathogen
detect
individu
assay
ep
assay
correl
poorli
assay
detect
adenoviru
kappa
valu
xtag
rvp
ftd
inhous
assay
seven
sampl
posit
ep
assay
may
infer
ep
assay
produc
fals
posit
adenoviru
result
sampl
seri
possibl
explan
ep
assay
use
nonspecif
dna
bind
dye
melt
curv
analysi
therefor
poor
primer
design
would
produc
nonspecif
pcr
product
similarli
xtag
rvp
moder
agreement
picornaviru
detect
kappa
valu
ftd
ep
inhous
assay
although
inhous
assay
restrict
rhinoviru
detect
differ
could
due
increas
sensit
xtag
pcr
detect
picornaviru
sampl
certain
strain
detect
primer
use
assay
differ
rhinovirus
exist
would
difficult
design
primer
detect
strain
pcr
effici
faux
et
al
recent
shown
optim
rhinoviru
detect
requir
two
primer
set
faux
et
al
least
agreement
assay
seen
human
bocaviru
kappa
valu
ftd
assay
versu
xtag
rvp
kappa
valu
zero
ep
versu
xtag
rvp
ftd
assay
detect
bocaviru
seri
sampl
low
valu
could
due
specif
sensit
issu
investig
requir
establish
whether
ftd
xtag
rvp
assay
produc
fals
posit
result
ep
assay
produc
fals
neg
result
due
strain
variat
opinion
assay
includ
compar
studi
could
use
laboratori
diagnost
tool
detect
common
respiratori
pathogen
limit
studi
carri
period
pdm
viru
domin
thu
could
comment
abil
assay
detect
pathogen
eg
influenza
b
hmpv
present
detect
small
number
therefor
studi
requir
note
differ
occur
assay
detect
rate
may
reflect
expect
assay
variabl
caus
select
gene
target
analyt
sensit
differ
equip
reagent
enzym
addit
perform
data
decid
assay
system
use
also
requir
inform
sampl
throughput
capabl
handson
time
technic
skill
requir
rang
target
detect
comparison
xtag
rvp
assay
requir
h
amplif
analysi
howev
could
process
sampl
includ
control
singl
run
offer
high
volum
throughput
h
work
day
gadsbi
et
al
xtag
rvp
open
system
assay
requir
oper
handl
pcr
product
product
detect
step
ftd
ih
pcr
requir
h
amplif
result
analysi
realtim
pcr
assay
run
three
wide
use
system
ftd
ih
pcr
assay
requir
signific
handson
time
setup
pcr
plate
step
could
semiautom
use
autom
pipet
platform
lead
reduc
labour
requir
ftd
inhous
pcr
assay
moder
sampl
throughput
sampl
per
run
run
eight
hour
day
extra
capac
could
obtain
use
rather
well
plate
advantag
realtim
pcr
format
close
system
requir
oper
manipul
pcr
product
amplif
product
detect
quantit
step
combin
singl
reaction
ep
assay
base
nest
pcr
principl
first
round
rtpcr
follow
second
round
pcr
pcr
call
multiplex
tandem
pcr
mtpcr
stanley
szewczuk
six
sampl
process
h
repres
low
throughput
capac
although
increas
addit
extra
real
time
pcr
thermal
cycler
advantag
xtag
rvp
ep
system
result
automat
gener
wherea
ftd
ih
assay
output
requir
complex
manual
analysi
gener
result
studi
sampl
collect
april
influenza
pdm
viru
first
detect
new
zealand
assay
abl
detect
influenza
xtag
rvp
although
detect
influenza
matrix
gene
target
assay
updat
primer
type
new
pdm
variant
influenza
untyp
result
indic
strain
ginocchio
st
georg
highlight
major
limit
commerci
assay
updat
primer
probe
sequenc
assay
market
problemat
contrast
inhous
assay
flexibl
design
rapidli
modifi
disadvantag
standardis
difficult
mani
variabl
pcr
workflow
impact
assay
perform
simpl
cost
analysi
perform
compar
assay
base
consum
labour
econom
assay
per
sampl
inhous
triplex
pcr
setup
develop
cost
exclud
easyplex
respiratori
panel
ftd
respiratori
pathogen
kit
final
xtag
rvp
cost
pcr
assay
mayb
higher
compar
classic
respiratori
pathogen
detect
procedur
howev
abil
multiplex
assay
provid
addit
pathogen
inform
rapid
time
frame
lead
save
patient
manag
four
multiplex
pcr
assay
assess
studi
show
high
degre
correl
detect
common
respiratori
virus
decis
best
assay
use
like
base
issu
sampl
throughput
staf
level
staff
expertis
clinician
expect
overal
fund
structur
